The MuLV 4070A G541R Env mutation decreases the stability and alters the conformation of the TM ectodomain  by Schneider, William M. et al.
Available online at www.sciencedirect.com
8) 165–174
www.elsevier.com/locate/yviroVirology 371 (200The MuLV 4070A G541R Env mutation decreases the stability and
alters the conformation of the TM ectodomain
William M. Schneider a, Haiyan Zheng b, Marie L. Coté a, Monica J. Roth a,⁎
a UMDNJ-Robert Wood Johnson Medical School, Department of Biochemistry, 675 Hoes Lane Rm. 636, Piscataway, NJ 08854, USA
b Center for Advanced Biotechnology and Medicine, Piscataway, NJ 08854, USA
Received 11 July 2007; returned to author for revision 30 July 2007; accepted 22 September 2007
Available online 24 October 2007Abstract
Virus–cell and cell–cell fusion events are affected by various properties of the fusogenic Env protein on the cell surface. The G541R mutation
within the TM ectodomain of murine leukemia virus (MuLV) 4070A arose by positive selection in viral passage and results in a reduction of cell–
cell fusion events while maintaining viral titer. Size exclusion chromatography shows that the multimerization properties are similar among
expressed wild-type and mutant ectodomain peptides. Circular dichroism measurements reveal decreased thermal stability of the G541R mutant as
compared to wild type. The G541R mutant also renders the peptide more susceptible to Lys-C protease cleavage. The 42–114 monoclonal
antibody does not bind to the G541R mutant peptides, suggesting a structural difference from wild type. These altered physical properties result in
productive viral infection of G541R bearing virus with decreased syncytia.
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Membrane fusion is a necessary event in the infectious cycle
of enveloped viruses and is therefore under strict spatial and
temporal control. Retrovirus membrane fusion is catalyzed by
the envelope (Env) surface (SU) and transmembrane (TM)
proteins. The SU protein is involved in receptor binding,
therefore providing specificity, while the TM protein contains
the necessary elements for membrane fusion. The Moloney
murine leukemia virus (Mo-MuLV) TM is initially expressed as
a precursor protein that is activated for viral fusion when the
viral-encoded protease (Pr) cleaves 16 amino acids from the C-
terminus. These 16 amino acids, known as the R-peptide,
negatively regulate membrane fusion (Rein et al., 1994). Along
with catalyzing virus–cell membrane fusion, the viral Env can
also induce cell–cell fusion. This results from the cell surface⁎ Corresponding author. Fax: +1 732 235 4783.
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receptors on neighboring cells.
Class I fusion proteins including MuLVs Env protein, human
immunodeficiency virus type I (HIV-I) Env, and influenza
hemagglutinin (HA) protein have evolved a similar method of
controlling membrane fusion (Ekert and Kim, 2001). All contain
a fusion peptide that is presumably buried in early envelope
conformations and subsequently exposed either in response to a
low pH endosomal compartment or conformational changes
following receptor binding. Upon exposure, the fusion peptide
inserts into the target cell membrane. This results in the TM
protein acting as a bridge linking the virus membrane to the
target cell membrane. It is at this stage that the TM protein
transitions into the highly stable post-fusion hairpin conforma-
tion. This physical process brings the two membranes within
close proximity thereby promoting membrane fusion and
content transfer (Ekert and Kim, 2001).
Altering expression levels of the TM and SU proteins has
been shown to affect membrane fusion in multiple viral systems.
The density of MuLV Env present on the cell surface can be
directly related to cell–cell fusion events (Chung et al., 1999).
However, virus–cell fusion is less affected and Mo-MuLV
Fig. 1. (A) Primary structure of 4070ATM protein and the TM55 construct. The
sequence of the entire 4070ATM protein is shown, with amino acid numbering
starting at the Met of the SU/TM signal peptide. Key features, including the
fusion peptide and transmembrane domain (shown in bold), are indicated as well
as the position of the G541R mutant. The region expressed in bacteria, which
corresponds to the TM55 protein is indicated by the arrows above the sequence
(T504–D556). The alpha-helical regions are indicated below the sequence:
Q503–F537 corresponds with the coiled-coil region and L543–L547 to the 310
helix, defined by the crystal structure of M-MuLV (Fass et al., 1996). The C-
terminal α-helix responsible for forming the six-helical bundle upon fusion
activation is outside the TM55 region. Sequence homologies with HTLV (Kobe
et al., 1999; Maerz et al., 2001) and Ebola (Weissenhorn et al., 1998a) have
predicted this alpha-helix to be located in the region of the gray box, with the
highest homology located in the dark gray region.
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(Bachrach et al., 2000). Similarly, a low density of influenza
hemagglutinin protein on the cell surface results in an increased
lag time before cell–cell fusion occurs (Clague et al., 1991;
Danieli et al., 1996). Consistent with this idea, cellular
expression levels of the HIV-1 Env protein has been shown to
alter cell–cell fusion (Lineberger et al., 2002).
Various mutations within the Env proteins also affect the
fusion process. Previous work has identified a point mutation,
G541R, within the ectodomain of the amphotropic 4070A TM
protein that was positively selected during viral passage. The
G541R mutation has been observed in chimeric (EA6 and EA7)
viruses in three independent populations as well as within a wild-
type (WT) 4070A virus passaged on D17 cells (O'Reilly and
Roth, 2003a,b; Peredo et al., 1996). G541 and G542 comprise a
Gly–Gly motif that is conserved among HTLV-1, Ebola, and
MuLV TM proteins adjacent to the conserved CX6CC motif
known to form a disulfide bond (Center et al., 1998; Fass et al.,
1996; Maerz et al., 2001; Weissenhorn et al., 1998b). The
phenotype associated with the G541R mutation is a decrease in
cell–cell fusion events despite near-wild-type viral titers, a
reduced cell surface density of Env protein, and a decrease in
SU-TM interactions (O'Reilly and Roth, 2003a). It has been
suggested that this Gly–Gly motif may act as a hinge region
allowing the putative post-fusion hairpin structure to arise
(Maerz et al., 2000). In the analogous region of HIV-1 gp41, a
Trp–Gly sequence is highly conserved among HIV and SIV
strains. In the HIV-1 gp41 ectodomain, a point mutation of the
Trp residue in this conserved Trp–Gly sequence results in a
decrease in cell–cell fusion and a mild decrease in gp120–gp41
interactions despite near wild-type viral fusogenicity (Cao et al.,
1994). The behavior exhibited by the G541R mutation within
theMuLVTM seems to parallel that observed in the mutant HIV-
1 gp41 ectodomain.
In an effort to understand how the G541R mutation results in
the observed phenotype, studies were performed to compare the
physical properties of purified TM ectodomain peptides (TM55)
encoding the WT and G541R mutation. Although multimeriza-
tion is not affected, the presence of the G541R mutation within
the 4070A TM ectodomain multimers results in a decrease in
thermal stability and an increased susceptibility to protease
digestion. The differential recognition of a monoclonal antibody
provides further support that the G541R mutation alters the
protein's 3D structure.
Results
Wild-type and G541R mutant protein have similar
multimerization properties
The ectodomain of the amphotropic 4070A TM was
expressed and purified from Escherichia coli. The region
expressed, from Thr503 to Asp 556 (TM55), was based upon
homology with the Mo-MuLV TM ectodomain, for which
biochemical analysis (Fass and Kim, 1995) and the X-ray
structure (Fass et al., 1996) has been determined. Fig. 1 profiles
the primary structure of the TM55 protein (region inclusive ofarrows) within the TM protein, based on the structure of Mo-
MuLV (Fass et al., 1996). The region encodes a putative coiled-
coil region (Q503–F537) followed by a short 310 helix. The
G541R mutation lies between the two helical domains. Three
conserved cysteines localize near the C-terminus of the peptide.
The short 310 helix is not similar to the alpha-helical region
found to intercalate into the coiled-coil region in the crystal
structures of HTLV (Kobe et al., 1999; Maerz et al., 2001) and
Ebola (Weissenhorn et al., 1998b), predicted to be further
towards the C-terminus.
The TM55 protein of both the wild-type 4070A (WT) and
the G541R mutant were expressed in a vector encoding an N-
terminal hexahistidine tag followed by a thrombin cleavage
site, facilitating a one-step purification on Ni-NTA resin under
native conditions. To determine if the G541R mutation would
alter the predicted trimeric multimerization of the protein, both
WT and G541R purified protein were size fractionated on a
Superdex 75 gel filtration column (Fig. 2). The predominant
protein peaks for both WT (Fig. 2A) and G541R (Fig. 2B)
elute at near identical volumes. Coomassie-stained SDS–
PAGE along with western blots using an anti-G541R antibody
(which recognizes the G541R and WT peptides) confirm that
the TM55 protein corresponds to the observed A280 peaks in
the chromatogram at fractions 19 and 20 (Fig. 2, arrow). The
co-elution of both the WT and G541R peptides in identical
fractions indicates no gross structural changes or alteration in
multimerization states has occurred. The majority of the
protein migrated as a monomer on the SDS–PAG. Low levels
of higher molecular weight products corresponding to
incompletely denatured TM55 multimers are also observed
in the fractions corresponding to the chromatogram peak.
Using a plot of the TM55 protein elution volume on the
Fig. 2. Superdex 75 FPLC elution profile of WT (Panel A) and G541R (Panel B). Molecular weight reference standards are depicted by arrows; mAU =
milliabsorbance units. The molecular masses of the peak fractions are indicated and were calculated based on the plot of the protein standards of Kav
1/3 vs. Molecular
weight0.555 (insert, panel A), as defined in the Materials and methods. Individual fractions were subjected to electrophoresis on a 17.5% SDS–PAGE and analyzed by
either Coomassie staining or western blot using an anti-G541RTM antibody. Corresponding fractions confirm the presence of the TM55 protein in the chromatogram
peak (arrow). Asterisks mark the position of incompletely denatured TM multimers. Reported molecular masses of the pre-stained molecular weight standards (Bio-
Rad Broad Range) are indicated at the left.
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standards, the TM55 migrated as a 36-kDa protein. Although it
would be expected that a trimer would elute at 25 kDa, the
coiled-coil structure likely results in a slower migration than
expected when plotted against globular molecular weight
standards.
The results of the Superdex 75 column chromatography
indicated that the mutation at G541R did not disrupt the overall
oligomerization of the TM ectodomain. This was expected given
that multimerization of TM is driven primarily through the
coiled-coil domain (Ou and Silver, 2005) and the G541R
mutation is C-terminal to this region.
Wild-type TM peptides are more thermodynamically stable
than G541R peptides
The G541R mutation lies within a Gly–Gly motif adjacent to
a cysteine-bonded loop highly conserved among HTLV-1,
Ebola, and MLV TM proteins (Maerz et al., 2001). In the
HTLV-1 TM structure predicted to represent the post-fusion
conformation, this region encompasses a turn and chain reversal,
which is stabilized by the disulfide bond (Maerz et al., 2001).
Experiments were therefore performed to examine whether the
G541R mutation would destabilize this region and decrease the
structural integrity of the peptide.To test this hypothesis, WT and G541R peptides were
thermally denatured (Figs. 3A and C), then renatured (Figs. 3B
andD) andmonitored for changes in the circular dichroism profile
(Aviv Spectropolarimeter Model 215 CD instrument). Studies
were performed using two buffer conditions: HEPES pH 7.4,
400 mM NaCl, 1 mM DTT, 5% glycerol, or phosphate buffer
(200 mMK2HPO4–KH2PO4 pH 8.0, 400 mMKCl). The peak of
the first derivative from the resulting curve was used as the mid-
point of transition (Tm), the temperature at which 50% of the
protein is folded. In both phosphate and HEPES buffer, the WT
peptides displayed higher melting temperatures than the G541R
peptides. In phosphate buffer the Tm of denaturation for WT is
74 °C while the Tm for G541R is only 67 °C (Fig. 3A). Protein
analyzed in HEPES buffer (Fig. 3C) gives a Tm of denaturation of
66 °C for WT and a Tm of 54 °C for G541R. The Tm of
renaturation was also measured in both phosphate and HEPES
buffers. In phosphate buffer, the Tm of renaturation ofWT is 67 °C
and 58 °C for G541R (Fig. 3B). In HEPES buffer, renaturation
yields a Tm of 73 °C for WT and 62 °C for G541R (Fig. 3D).
These studies indicate that the G541R mutation decreases
both the Tm of thermal denaturation and renaturation compared
to theWT TM peptide. This confirms the hypothesis that G541R
destabilizes the coiled-coil region. Despite these differences in
thermal stability, additional wavelength scans show both
proteins have an α-helix content of 65–70% and the proportion
Fig. 4. Time course of endoproteinase Lys-C digest visualized by Coomassie-
stained SDS–PAGE. The top panel shows the primary sequence of the histidine
tagged TM55 protein with arrows indicating the expected protease cleavage
sites. Lys-C digestion of wild-type TM55 (Panel A) and G541R TM55 (Panel
B). Sensitivity to protease cleavage is seen as the disappearance of full-length
TM55 protein product (marked by arrows) over time. Time of Lys-C digestion
(hours) is indicated below the panels. Molecular weight protein standards are
indicated at the left of the panels. Asterisks (⁎) mark the presence of proteolytic
fragments.
Fig. 3. Thermal denaturation/renaturation of WT and G541R. Thermal
denaturation profiles of WT (closed circles) and G541R (open circles) in
phosphate buffer (A) and HEPES buffer (C). Thermal renaturation profiles of
WT (closed circles) and G541R (open circles) in phosphate buffer (B) and
HEPES buffer (D). The midpoint of transition (Tm) as determined from the first
derivative of the curves is labeled in the panels (°C).
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between the two peptides (data not shown). This observation
argues that the thermostability differences observed likely result
from a local deformation in the structure.
Wild-type TM peptide is more resistant to protease digestion
than G541R
The location of the G541R mutation along with the observed
structural thermal instability it imparts suggests the possibility
that the arginine substitution may reduce the flexibility in the
hinge region. This limited flexibility could then prevent opti-
mal hairpin formation resulting in weaker interactions among
the N-terminal helices and the C-terminal tail in the trimer. If
this is true, the G541R peptide should be significantly more
susceptible to protease cleavage compared to WT TM peptide.
To test this, a time course of protease digestion was carried out
using Endoproteinase Lys-C (Lys-C). Lys-C enzyme cleaves
peptide bonds C-terminally at lysine residues. The TM55
protein contains four lysines that could be cleaved by Lys-C
(Fig. 4, top). The first two are within the triple-helical region,
the third lies between the C-terminus of the coiled-coil and the
G541R mutation, and the fourth lysine is within the CX6CC
motif (Fig. 1). Digestion at a single lysine would result in loss of
the full-length TM55 product.
Coomassie-stained SDS–PAGE analysis of WT and
G541R treated with Lys-C shows the loss of the full length
TM55 peptide with protease digestion and the concomitant
appearance of degraded products at the bottom of the gel,
denoted by an asterisk. The WT TM peptide (Fig. 4A) ishighly resistant to Lys-C digestion at time points up to 24 h
while G541R (Fig. 4B) displays complete digestion within the
first hour after addition of protease. Given the location of the
mutation it is possible the susceptibility to protease digestion
results from a disruption of the predicted disulfide bond that
likely adds stability to the region. However, the addition of
TCEP prior to digestion had a minimal effect on digestion of
the WT and G541R peptides at time points of 1 h and after
(data not shown). This suggests that while the predicted
disulfide that forms between two cysteines in the hairpin loop
may provide some resistance to protease digestion, its
presence or absence cannot explain the difference found
between WT and G541R.
Wild-type and G541R protein both have an intact disulfide
bond
In order to determine if the G541R mutation could interfere
with the formation of the expected disulfide bond, experiments
to identify the disulfide bonds were performed on both the WT
and G541R TM55 peptides. The approach involved the modi-
fication of the protein samples using the alkylating agent
iodoacetamide (IAM), and subsequently analyzing their mass
spectra. Free cysteine residues will be alkylated by IAM,
whereas cysteines that are disulfide bonded will not be modified.
Following treatment with IAM, the peptide samples were treated
with high concentrations of Lys-C to maximize proteolysis and
analyzed by mass spectrometry to identify the presence and
location of disulfide bonds. Figs. 5A and C show respectively
that WT and G541R peptides treated with IAM followed by
digestion with Lys-C yielded fragments with a mass of 1876.9
Fig. 5. Mass spectrometry of WT and G541R. Peptide samples were treated in
the presence or absence of DTT reducing agent followed by IAM alkylation and
digestion with Lys-C. Products were then subjected to mass spectrum analysis.
Panels A and B: WT peptide. Panels C and D: G541R peptide. The samples in
panels B and D were reduced prior to alkylation. Peaks are labeled according to
amino acid residues and modifications present. Alkylated cysteine residues are
denoted by an asterisk (⁎). Putative disulfide bonds are labeled as cysteine
residues joined with lines; however, the exact cysteines involved in the cysteine
bond cannot be determined from the analysis.
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for peptides with the addition of one modification along with
the loss of 2 protons from the formation of a disulfide bond.Control samples of the WT and G541R peptides were
created by initially reducing with DTT then observing their
mass spectra. Fragments of 1992.8 amu and 2091.9 amu
appear for WT and G541R respectively, corresponding in
size to the modification of all three cysteines (Figs. 5B and D).
It should be noted that despite reduction and modification of all
three cysteine residues, fragments corresponding to cleavage at
the lysine residue within the CX6CC motif were never
observed (including LC-MS analysis using LTQ Thermo-
Fisher; data not shown). This suggests steric constraints
prevent cleavage at this particular site regardless of disulfide
bonding.
The analysis performed identified one disulfide bond but
does not specify which two cysteines are involved in the
disulfide bond. To determine whether the disulfide occurs
between the first and second cysteine residues in the CX6CC
motif as expected, MALDI-TOF/TOF (MS/MS) was per-
formed. To map cystine bonds, protein fragments from the
first TOF MS were subsequently fragmented in a second TOF
MS and the mass of each sequential amino acid in the peptide
chain was analyzed allowing for the identification of the IAM
modified cysteine. MS/MS analysis indicated that there does
in fact exist a disulfide bond between the first and second
cysteine residues; however, there also exists a population in
both WT and G541R peptides that contains a disulfide bond
between the vicinal cysteine residues (data not shown).
However, because this analysis was not coupled with liquid
chromatography the two species could not be separated
quantitatively, and it is therefore not possible to conclude
whether the G541R mutation favors one conformation over
another. This unexpected finding may be a result of
expression of subdomains in bacteria or disulfide shuffling
during the analysis, although a possible biological function
cannot be eliminated.
The G541R mutation abrogates binding of a TM-specific
antibody
The observed differences in physical properties exhibited by
WT and G541R suggest that disparities in physical structure
were quite likely. Fig. 6 shows the results obtained from probing
western blots of bacterially expressed TM55 with either a TM-
specific (42–114) antibody (Fig. 6A) or an anti-polyhistidine
antibody (anti-polyHis6) (Fig. 6B). Panel A shows the 42–114
antibody recognized WT (lane 3) but not G541R (lane 5) from
E. coli soluble cell lysates. Total cell extract (lane 8) from
E. coli expressing the G541R mutant reacts weakly. Panel B
shows that both the WTand G541R proteins are present in equal
amounts in the soluble fractions (lanes 3 and 5 respectively), as
seen by a western blot with an anti-polyHis6 antibody. The
monoclonal TM-specific 42–114 antibody differentiates be-
tween the WT and G541R peptides, either due to changes in the
conformational epitope, or disruption of a sequence-specific
epitope. However, weak binding of 42–114 to G541R peptides
in total cell extracts (Fig. 6A, lane 8) implies that there is a
population of G541R present that can bind the antibody. The
differences in antibody recognition between the wild-type and
Fig. 6. Differential recognition of TM by monoclonal antibody 42–114 versus anti-His antibody. The panel represents western blots of bacterial cell lysates expressing
TM peptides probed with TM-specific monoclonal antibody 42–114 (A) or monoclonal anti-polyhistidine antibody (B). The grid at top defines the constructs and
antibodies used; the bottom labels the extracts: S, soluble bacterial cell lysate; I, insoluble bacterial cell lysate; T, total bacterial cell lysate; N, NiNTA bound G541R;
pET, empty vector bacterial cell control. Position of the molecular weight standards is indicated. Arrow marks the position of the TM55 monomer.
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result from the mutation.
Discussion
The G541R mutation within the amphotropic MuLV TM
protein was previously found in multiple viral populations in-
cluding WT 4070A virus as well as three independent
populations of chimeric (EA6 and EA7) virus (O'Reilly and
Roth, 2003b). The phenotype associated with this mutation
exhibits decreased syncytia formation despite near wild-type
viral titers. In addition, there is a decrease in co-immunoprecip-
itation of the TM with SU protein with an anti-SU polyclonal
antibody (80S-019) and decreased cell surface expression of the
SU/TM protein (O'Reilly and Roth, 2003a). Since virus–cell
membrane fusion is maintained in the presence of G541R, it was
expected that TM proteins bearing G541Rwould undergo all the
conformational changes required for productive entry into the
host cell. However, the equilibrium and kinetics between these
intermediate states would most likely differ in virus bearing the
WT and G541R proteins. To better understand how the G541R
mutation within the TM protein could lead to the observed
phenotype, we sought to purify and study a recombinantly
expressed portion of the TM ectodomain harboring this
mutation.
It is probable that the WT 4070A TM protein also forms a
trimer given the high sequence homology shared with the
ecotropic Mo-MLV TM, HTLV-1 gp21, and Ebola GP2 proteins
(Maerz et al., 2001). These homologous proteins along with
various other class I membrane proteins have been crystallized
previously and shown to form trimers (Fass et al., 1996; Kobe
et al., 1999; Lu et al., 1995; Weissenhorn et al., 1998b; Wilson
et al., 1981; Yang et al., 1999). To date, all of the structures
formed from bacterial expression of class I TM ectodomains are
consistent with the six-helical representative of the post-fusion
state. It was therefore expected that the trimeric structure would
exist in both the WTand G541R peptides. Gel filtration analysis
has shown that the G541Rmutation within the TM does not alter
the multimerization state of the protein as both the WT and
G541R peptides elute at near identical volumes. The molecularweight of the purified monomer is roughly 8.3 kDa. When the
Superdex 75 elution profile was plotted against a standard curve,
the TM55 protein appears to elute as a 36-kDa species,
suggesting a tetrameric state. However, the protein can still be
a trimer with a slower elution due to its extended coiled-coil
structure. This phenomenon has also been seen with the HTLV-1
gp21 protein when analyzed by gel filtration; however, sedi-
mentation equilibrium profiles (Center et al., 1998) and the
subsequent X-ray crystal structure (Kobe et al., 1999) confirm
the trimer structure. Most importantly, elution at near identical
volumes suggests that both WT and G541R form the same
quaternary structure.
Viral fusion proteins are characteristically high in α-helix
content and have high thermostability (Blacklow et al., 1995;
Chen et al., 1995; Fass and Kim, 1995; Ruigrok et al., 1988,
1986; Weissenhorn et al., 1998a, 1996). Both WT and G541R
peptides also had high α-helix content (65–70% by CD);
however, the G541R mutation significantly decreased the ther-
mal stability of the TM peptide. When analyzed in two different
buffer conditions, the G541R mutant peptides denatured and
renatured at consistently lower temperatures than the WT pep-
tides. The results presented in this manuscript indicate that the
G541R mutation, which is outside the coiled-coil region, affects
the stability of the triple-helical regions.
G541R substitutes Arg for the first Gly within a Gly–Gly
dipeptide, known to be extremely flexible in its potential rota-
tions. Introduction of the large charged Arg within this motif
restrains the peptide chain's rotational conformations and most
likely imparts unfavorable constraints on the flanking regions.
G541R immediately precedes the conserved CX6CC motif that
is predicted to form a disulfide bond between the first and
second cysteine residues. This proposed disulfide linkage is
based upon X-ray structural data of homologous fusion proteins
(Fass et al., 1996; Fass and Kim, 1995; Kobe et al., 1999;
Weissenhorn et al., 1998b). Experiments presented herein in-
dicate that the G541R mutation does not prevent the formation
of the disulfide bond. Thus, the observed thermal instability and
susceptibility to protease digestion of the G541R mutant protein
cannot be explained by an inability of the mutant protein to form
a disulfide bond.
Fig. 7. A superpositioning of the backbone of the proposed G541R monomer
(gold) onto the known 1mof (cyan) monomer structure. Side chains of
critical residues are shown and labeled using the same color scheme. The
structural alteration resulting from the Arg substitution is evident in the
relaxation/lengthening of the 310 helix and the increased disulfide bond
distance. These subtle alterations could propagate along the chain to the C-
terminal helix and result in weakened packing interactions among the N- and
C-terminal helices.
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from forming, it did not rule out the possibility that the disulfide
bond was forming between cysteine residues in the motif other
than the two expected. To clarify this point, MS/MS analysis
was performed and it was in fact determined that a disulfide
bond occurs between the first and second cysteine residues as
expected. Interestingly, MS/MS data show that there is also a
population in which the disulfide bond occurs between the
second and third (vicinal) cysteines. This is seen in both WT as
well as the G541R mutant protein. Since the data collected is
only qualitative, it is not possible to conclude whether or not the
G541R mutation affects the likelihood of one bond forming
over the other. Within the pre-fusion state, SU-TM interaction is
through non-covalent as well as covalent interactions. For
MuLV, a disulfide bond between the TM CX6CC region and the
CWLC region of SU has been identified (Pinter et al., 1997),
which undergoes thiol-isomerization upon receptor binding
(Wallin et al., 2005a,b). While it remains possible the vicinal
cysteine bond observed is an artifact of the purification pro-
cedure or mass spectrometry technique, a high energy vicinal
disulfide bond in the extended pre-fusion state may have a
biological role. A high energy disulfide bond stabilized by
interactions with the SU protein may serve to increase the free
energy release when the SU protein is shed and the transition to
a post-fusion state is made. In this model the first cysteine
residue would be involved in the disulfide bridge linking the SU
and TM proteins. Upon receptor binding, the disulfide bridging
the SU and TM proteins would be disrupted creating a redox
switch in TM, similar to the redox switch believed to exist in the
SU protein (Pinter et al., 1997). This would result in the
breaking of the vicinal disulfide bond and the formation of the
post-fusion conformation, with a lower energy disulfide bond
forming between the first and second cysteine in the CX6CC
motif. While a biological role cannot be ruled out, further
investigation would be required to test this hypothesis.
While the G541R mutation does not appear to result in a
dramatic structural change within the ectodomain, at least in the
post-fusion form, the results of these studies support a
detectable, but subtle local destabilization that decreases the
integrity of the multimer. In addition to the physical (thermal
denaturation/renaturation studies) and biochemical (Lys-C
digestion) evidence, additional support is provided by the
differential recognition of the wild-type and mutant proteins by
the monoclonal antibody 42–114. The 42–114 anti-TM
antibody binds the WT TM55 peptide; however, it shows low
recognition of the TM55 bearing the G541R mutation. If the
antibody is in fact recognizing a specific conformation, even
subtle structural differences within this region could alter the
association of TM with SU. Alteration in the positioning of the
CX6CC could readily affect the ability to form the SU-TM
disulfide bond as well as destabilize non-covalent interactions
yielding the observed decrease in Env on the cell surface
previously reported (O'Reilly and Roth, 2003a).
Fig. 7 shows a molecular model representing possible struc-
tural changes in the TM protein due to the G541R mutation. In
HTLV-1 gp21, the Gly–Gly dipeptide forms a hinge fold-back
region, allowing the C-terminal residues to pack tightly with theresidues in the N-terminal helices (Maerz et al., 2000). Mole-
cular modeling of G541R based on the known ecotropic MuLV
TM55 protein indicates the regions flanking the Arg-Gly
dipeptide are in an altered conformation. This is in agreement
with the Lys-C digestion, indicating the altered conformation
may render the mutant more susceptible to Lys-C digestion. The
alteration in the structure near the hinge also affects the potential
to maintain the disulfide bonding between the SU and TM
proteins. The model shows the orientation of the two disulfide
bonded cysteine residues is altered and there is an increase in
the S-S bond distance. In addition, differences within the
cysteine-bonded loop may negatively affect the ability of the
monomers to pack tightly into a trimer. Weaker packing inter-
actions, leading to a more solvent exposed conformation, would
explain the decreased thermostability as well as the increased
susceptibility to protease digestion.
A decrease in the cell surface concentration of Env protein
along with the decreased structural integrity reported herein
may account for the observed reduction in syncytia formation
while at the same time allowing for viral titers to remain within
wild-type levels. Mutations in the HIV-1 gp41 Trp–Gly motif,
amino acid substitutions in the amino terminus of gp41, or
proline substitutions in either of the two conserved glycines in
the Gly–Gly motif result in a similar phenotype (Kowalski
et al., 1991; Maerz et al., 2000, 2001). It has been suggested that
a greater quantity of Env on the surface is required for cell–cell
fusion than is required for virus–cell fusion (Bachrach et al.,
2000; Cao et al., 1994; Kowalski et al., 1991). A decrease in
fusogenic potential along with a decreased surface expression
of TM harboring the G541R mutation could thus provide a
means to balance cytopathogenicity with productive viral
infection.
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Production and purification of TM peptides
The DNA sequence encoding amino acids T503–D556 was
PCR amplified from wild-type and G541R proviral DNA using
a forward primer introducing a 5′ NdeI site (5′-GAATTCCA-
TATGACAGACCTCAACGAAGTC-3′) and a reverse primer
encoding a 3′ BamHI site (5′-CGGGATCCCGTCAGTCTG-
CATAAAAACAACA-3′). PCR products were then cloned into
a pET 11d vector (Studier et al., 1990) and a 6HisT-pET11 vector
(T= thrombin cleavage site) yielding the TM55 construct
(Hoffmann and Roeder, 1991). E. coli BL21 (DE3) cells
expressing WTand G541RTM peptides (TM55) were grown to
an OD600 of 0.6 at 37 °C and induced with 1 mM IPTG. After
3 h, bacterial cultures were harvested by centrifugation. To
obtain total cell extract, the pellet was resuspended in 40 μL of
cracking buffer (10 mM Na2HPO4–NaH2PO4 pH 7.2, 142 mM
2-mercaptoethanol (βME), 1% SDS, 6M urea) per 1 mL of cell
culture. For purification, pellets were resuspended to 40 μL /
1 mL cell culture in solubilization buffer containing 50 mM
Na2HPO4–NaH2PO4 pH 8.0, 10 mM CHAPS, 10 mM imidaz-
ole, 300mMNaCl, with 1 protease EDTA free tablet (Roche Cat.
# 11 873 580 001) per 50 mL. Pellets were dounce homogenized
and sonicated to lyse the cells, then centrifuged for 1 h at
16,000 rpm in a Sorvall SS-34 rotor. The insoluble pellet was
resuspended in cracking buffer as above, boiled for 10 min, and
analyzed along with supernatant by SDS–PAGE. The TM55
supernatant was then further purified by binding to Ni-NTA
resin at 40 mL of extract per 1 mL bed resin. Resin was washed
twice with 10 mL wash buffer containing 50 mM Na2HPO4–
NaH2PO4 pH 8.0, 10mMCHAPS, 50mM imidazole, 1MNaCl,
5 mM βME, and 10% glycerol. The protein was then eluted with
5 mL buffer containing 250 mM imidazole per 1 mL bed resin.
The protein was then dialyzed into either 20 mM Tris–HCl pH
8.8 for Lys-C digest, buffers specified for FPLC gel filtration, or
buffers specified for circular dichroism thermal denaturation/
renaturation experiments, as indicated.
Lys-C digest
Twenty microliters of a 1 mg/mL protein solution of both
wild-type and G541R mutant TM 55 protein was brought to
80 μL in a final concentration of 100 mM Tris–HCl pH 8.5, 6 M
urea, and 10 mM iodoacetamide (IAM) in the presence or
absence of 5 mM Tris(2-carboxyethyl) phosphine hydrochlo-
ride (TCEP). Samples were incubated at 37 °C for 15 min in the
dark. Endoproteinase Lys-C (0.1 μg; Roche Cat. # 11 420 429
001) was then added to protein solutions and the mixture was
brought to a final volume of 120 μL with 100 mM Tris–HCl
pH 8.5, 4.0 M urea, 6.7 mM iodoacetamide, with and without
3.3 mM TCEP as indicated. Digest reactions were then
incubated at 37 °C in the dark for 1 h, 2 h, 3 h, 4 h, and 24 h.
Reactions were quenched with the addition of SDS–PAGE gel
loading dye bringing samples to a final concentration of 2%
SDS, boiled for 10 min, and stored at −20 °C prior to SDS–
PAGE analysis.Western blots
Monoclonal anti-polyhistidine (Sigma Cat. # H1029) was
used at a dilution of 1/3000.Monoclonal anti-TM42–114 (Pinter
et al., 1982) was used at a dilution of 1/500 and polyclonal anti-
G541R was used at a dilution of 1/15,000. Anti-G541R rabbit
polyclonal antibody was generated by Cocalico Biologicals, Inc.
using as antigen G541R TM 55 purified from a soluble E. coli
lysate on NiNTA agarose resin via the N-terminal histidine tag
under native conditions. Anti-G541R reacts with both WT and
G541RTM 55 peptide. Secondary antibody used in monoclonal
antibody experiments was a 1/1000 dilution of anti-mouse IgG
biotin conjugate (SigmaCat. # B7264). Secondary antibody used
in polyclonal anti-G541R experiments was anti-rabbit IgG biotin
conjugate (Sigma Cat. # B7389). Visualization with alkaline
phosphatase was achieved using the Vectastain™ ABC kit
(Vector Laboratories Cat. # AK-5000).
Circular dichroism spectroscopy
Thermal denaturation/renaturation experiments were carried
out on an Aviv Spectropolarimeter Model 215 at the UMDNJ
Circular Dichroism Facility. Wild-type (0.2 mg/mL) and G541R
mutant (0.3 mg/mL) TM 55 proteins were analyzed in both
HEPES buffer (50 mM HEPES pH 7.4, 400 mM NaCl, 1 mM
DTT, 5% glycerol) and phosphate buffer (200 mM K2HPO4–
KH2PO4 pH 8.0, 400 mM KCl). Thermal denaturation
experiments were performed from 10 °C to 80 °C. The CD
signal was measured in steps of 0.2 °C, equilibration time
0.2 min, averaging time 5.00 s. Thermal renaturation experi-
ments were carried out as described above starting at 80 °C and
ending at 22 °C. The Tm for each protein was determined from
the peak of the first derivative of the ellipticity vs. temperature
curve.
FPLC gel filtration
Gel filtration was performed on an AKTA FPLC (Amersham
Pharmacia Biotech) using a Superdex 75 HR10/30 column.
250 μL of a 4 mg/mL protein solution was injected into a 500-μL
sample loop following the partial fill method. The flow rate was
set at 0.500 ml/min and samples were collected in 500 μL
fractions. Samples were run in 200 mM K2HPO4–KH2PO4 pH
8.0, 400 mM KCl, 1 mM DTT. The molecular weight standards
used for size determination consisted of a 250-μL solution con-
taining 2 mg/mL blue dextran, 1 mg/mL bovine serum albu-
min, 2.4 mg/mL ovalbumin, 0.6 mg/mL carbonic anhydrase,
0.64 mg/mL cytochrome c, and 2 mg/mL aprotinin. A linear
relationship between elution volume and molecular weight
was generated by plotting Kav
1/3 vs. Molecular weight0.555c. Kav=
(Vr−V0) / (Vc−V0), where Vr =elution volume of protein, V0=
void volume of column, and Vc=bed volume of column.
Mass spectrometry
Ten micrograms of wild-type and G541R mutant TM 55
proteins was prepared for mass spectrometry by first adding 8M
173W.M. Schneider et al. / Virology 371 (2008) 165–174urea and 20 mM methylamine. Samples were incubated either
with 10 mM DTT to reduce disulfide bonds, or without DTT as
a control for 30 min at 60 °C. Twenty millimolar iodoacetamide
was then added to each sample; and the samples were placed in
the dark for 1 h at room temperature to alkylate the sulfhydryl
groups. An equal volume of (NH4)HCO3 was then added to the
sample prior to Lys-C digestion (1:100 protease: protein, at
37 °C overnight.) After digestion, approximately 0.5 pmol of
sample was treated with ziptipC18 (Millipore, Billerica, MA)
and eluted with 1 μl of 2.5 mg/ml alpha-cyano-4-hydrocinnamic
acid in 0.1% TFA, 50% acetonitrile directly on an opti-TOF 384
plate (Applied Biosystem/Sciex).
MALDI-TOF TOFMS analysis was performed using a 4800
TOF/TOF analyzer (Applied Biosystems/MDS Sciex). MS was
collected using positive reflectron mode, mass range 800 amu to
4000 amu. Each spectrum is an average of 500 laser shots with
fixed intensity. Calmix1 (des-Arg-Bradykinin, anigotensin1,
Glu-Fibrinopeptide B, ACTH (Clip 1–17), ACTH (Clip 18–29),
ACTH (Clip 7–38), Applied Biosystem) was used for external
calibration. MS/MS was performed with collision gas on, 1000
laser shots were accumulated for one spectrum. B fragments
of Glu-Fibrinopeptide were used for external calibration of
MS/MS.
G541R modeling
The 1mof crystal structure (Fass et al., 1996) from D46 to
D98 was input into the program O. Modifications comprised the
addition of Q44 and T45 at the N-terminus, mutation of G83R
(G541R), and substitution of the 4070A sequence at residue
A94C. The ϕ/φ angles of G541R were adjusted to reside in the
allowed loop region of a Ramachandran plot. K81 and K90 were
placed with idealized side chains, in their statistically most
probable conformations. This model was then modestly
minimized, using only torsion angle dynamics. A trimer model
was then created via superpositioning onto the known
crystallographic model of 1mof (using symmetry elements 1,
4, and 7). The trimer model was subjected to full gradient
minimization in vacuo using the Amber 8 Suite of programs
(Case et al., 2005). The final model remained as a symmetric
trimer, with one monomer rendered in the figure.
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